DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/6s7b99/procter_and) has announced the addition of the "Procter & Gamble Co,The in Consumer Health" company profile to their offering.
In consumer health P&G relies on only a handful of key brands - Vicks, its flagship consumer health brand and Prilosec, limited to the US market and facing long-term decline. The move in 2011 to partner with Teva Pharmaceuticals may offer a solution, giving it access to new markets and piggybacking off Teva's stronger drug pipeline and research and development capacity. Launches in a number of Eastern European markets of the Vicks brand are already well underway, led by Teva.
Euromonitor International's Procter & Gamble Co,The in Consumer Health Company Profile offers detailed strategic analysis of the company's business, examining its performance in the Consumer Health industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.
Why buy this report?
- Get a detailed picture of the Consumer Health market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Key Topics Covered:
Scope of the Report
Category and Geographic Opportunities
For more information visit http://www.researchandmarkets.com/research/6s7b99/procter_and.
Source: Research and Markets